Dr. Irmi Huber is a seasoned MD and entrepreneur in the healthcare industry with 30 years of expertise. As the Co-founder and CEO of Neotes GmbH since 2020, she leads a pioneering longevity platform in Europe. Additionally, she serves as the Co-managing Partner at Sanoptis SA in Greece, implementing a Buy&Build strategy in Ophthalmology.

     Dr. Huber is a Business Angel and Co-founder of thebluelife.de, a digital biomarker for vascular diseases. Her diverse experience includes roles as a consultant, officer, and shareholder in various healthcare projects globally.

     Dr. Huber holds a medical degree, a doctorate from Joh. Gutenberg University, and has international education and fellowship experiences.